Ken Griffin
SRRA

Ken Griffin’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Ken Griffin’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,600
Closed -$308K – 14294
2022
Q2 		$308K Sell
5,600
-11,000
-66% -$577K ﹤0.01% 9750
2022
Q1 		$532K Buy
+16,600
New +$476K ﹤0.01% 9244

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Ken Griffin's SRRA Position: Q3 2022 in Review

Ken Griffin sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 6,406 shares — an estimated $352K sold.

Ken Griffin first reported a position in SRRA in Q3 2015 and held it in 12 quarters. The position peaked at $15M in Q1 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • Ken Griffin reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Ken Griffin sold 6,406 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $352K.
  • Ken Griffin first reported a position in Sierra Oncology, Inc. Common Stock in Q3 2015 and held it in 12 quarters.
  • Ken Griffin's Sierra Oncology, Inc. Common Stock position peaked at $15M in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.